Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Oct 11, 2024 8:40am
95 Views
Post# 36262354

New York Cannabis Sales Continue to Surge

New York Cannabis Sales Continue to Surge


The surge since May ties into a stronger effort to close unlicensed dispensaries. Weekly sales have surged 75% since May 25th. We picked up on this three months ago in the NCV weekly newsletter, where we pointed out that New York cannabis was booming.

Three months ago, we reported that there were 144 adult-use stores in the state, and now there are 210. The store growth has been strong both in the NYC and Long Island area, where 94 stores are now open (4 on Long Island), and upstate NY, where there are now 116 open.

In Q3, total adult-use sales reached $250 million and rose 54% sequentially and 357% from a year earlier. The New York market is growing, but it has a lot more room to grow. It is the fourth largest state by population, with about half of the population of California. That state is not exactly booming, but its Q3 total sales were estimated by BDSA to be $1.26 billion, about 5X the level of New York sales. New York is growing strongly, while California sales shrank 1% from a year earlier.

New York continues to offer its consumers a better market, and there are plenty of public companies that are serving it. The public companies dominated the small medical cannabis market, but several are starting to build up their efforts in adult-use. Curaleaf and Green Thumb Industries each operate 3 adult-use stores, while Acreage, Cannabist, Cresco Labs, iAnthus and Vireo don’t operate any yet. MedMen, which is bankrupt no longer operates in the state. Riv Capital owns Etain, and it has 3 adult-use stores now. Pharmacann, which has an investment from Cronos Group, operates 1 too (Verilife).

https://www.newcannabisventures.com/new-york-cannabis-sales-continue-to-surge/

<< Previous
Bullboard Posts
Next >>